Tapewire

Nasdaq · USD

CDNA

CareDx, Inc.

Export transactions ↓
Tapewire entity
4344
SEC CIK
0001217234
Parsed reports
707

Last 12 months

Inside the activity.

0 purchase rows · 26 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202502
Jan 202603
Feb 202601
Mar 202600
Apr 202601
May 202603
Jun 202606
Jul 202604
Aug 202605
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 02, 2018 Filed Jul 3, 2018 17:43 UTC
Nelles Mitchell JChief Operating Officer
Exercise / conversionCommon Stock 9,000 $2.30 $20,700.00
Disclosure

SEC source: 0000899243-18-019286 · doc4.xml · nonDerivative · entry 5

Nelles Mitchell J · CIK 0001421333 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 126,538

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 02, 2018 Filed Jul 3, 2018 17:43 UTC
Nelles Mitchell JChief Operating Officer
Exercise / conversionCommon Stock 19,250 $5.27 $101,447.50
Disclosure

SEC source: 0000899243-18-019286 · doc4.xml · nonDerivative · entry 4

Nelles Mitchell J · CIK 0001421333 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,538

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 02, 2018 Filed Jul 3, 2018 17:43 UTC
Nelles Mitchell JChief Operating Officer
Exercise / conversionCommon Stock 3,649 $3.70 $13,501.30
Disclosure

SEC source: 0000899243-18-019286 · doc4.xml · nonDerivative · entry 3

Nelles Mitchell J · CIK 0001421333 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,288

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 02, 2018 Filed Jul 12, 2018 19:23 UTC Amendment
Nelles Mitchell JChief Operating Officer
SaleCommon Stock 39,649 $12.48 $494,910.71
Disclosure

SEC source: 0000899243-18-019829 · doc4a.xml · nonDerivative · entry 5

Nelles Mitchell J · CIK 0001421333 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,160

F2 · balance_after: This line item is being amended and restated to correct the amount of securities beneficially owned following the subsequent reported transactions.

Read SEC document
July 02, 2018 Filed Jul 12, 2018 19:23 UTC Amendment
Nelles Mitchell JChief Operating Officer
Exercise / conversionCommon Stock 9,000 $2.30 $20,700.00
Disclosure

SEC source: 0000899243-18-019829 · doc4a.xml · nonDerivative · entry 4

Nelles Mitchell J · CIK 0001421333 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,809

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · balance_after: This line item is being amended and restated to correct the amount of securities beneficially owned following the subsequent reported transactions.

Read SEC document
July 02, 2018 Filed Jul 12, 2018 19:23 UTC Amendment
Nelles Mitchell JChief Operating Officer
Exercise / conversionCommon Stock 19,250 $5.27 $101,447.50
Disclosure

SEC source: 0000899243-18-019829 · doc4a.xml · nonDerivative · entry 3

Nelles Mitchell J · CIK 0001421333 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,809

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · balance_after: This line item is being amended and restated to correct the amount of securities beneficially owned following the subsequent reported transactions.

Read SEC document
July 02, 2018 Filed Jul 12, 2018 19:23 UTC Amendment
Nelles Mitchell JChief Operating Officer
Exercise / conversionCommon Stock 3,649 $3.70 $13,501.30
Disclosure

SEC source: 0000899243-18-019829 · doc4a.xml · nonDerivative · entry 2

Nelles Mitchell J · CIK 0001421333 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,559

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · balance_after: This line item is being amended and restated to correct the amount of securities beneficially owned following the subsequent reported transactions.

Read SEC document
July 01, 2018 Filed Jul 3, 2018 21:35 UTC GrantStock Option (right to buy) · Derivative 30,000 $0.00 Strike: $12.88 $0.00
Disclosure

SEC source: 0000899243-18-019278 · doc4.xml · derivative · entry 2

Abernethy Amy · CIK 0001590728 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2028-07-01

F2 · derivative.exercise_date: 1/36th of the shares subject to the option shall vest on August 2, 2018 and 1/36th of the shares subject to the option shall vest monthly thereafter.

Read SEC document
July 01, 2018 Filed Jul 3, 2018 21:35 UTC GrantCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-019278 · doc4.xml · nonDerivative · entry 1

Abernethy Amy · CIK 0001590728 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

F1 · shares: The reported securities are represented by restricted stock units 1/3rd of which shall vest on July 1, 2019 and 1/3rd of which shall vest on each anniversary thereafter.

Read SEC document
June 29, 2018 Filed Jul 3, 2018 17:26 UTC GrantCommon Stock 740 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-019269 · doc4.xml · nonDerivative · entry 1

HAGSTROM WILLIAM A · CIK 0001042875 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,272

F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Read SEC document
June 29, 2018 Filed Jul 3, 2018 17:31 UTC GrantCommon Stock 1,197 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-019273 · doc4.xml · nonDerivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,996

F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Read SEC document
June 29, 2018 Filed Jul 3, 2018 17:39 UTC
King SashaChief Commercial Officer
GrantEmployee Stock Option (right to buy) · Derivative 50,000 $0.00 Strike: $12.24 $0.00
Disclosure

SEC source: 0000899243-18-019282 · doc4.xml · derivative · entry 3

King Sasha · CIK 0001721150 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2028-06-29

F3 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on June 1, 2019 and 1/48th of the shares subject to the option shall vest monthly thereafter.

Read SEC document
June 29, 2018 Filed Jul 3, 2018 17:39 UTC
King SashaChief Commercial Officer
GrantCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-019282 · doc4.xml · nonDerivative · entry 2

King Sasha · CIK 0001721150 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,500

F2 · shares: The reported securities are represented by restricted stock units, 100% of which were vested upon grant.

Read SEC document
June 29, 2018 Filed Jul 3, 2018 17:39 UTC
King SashaChief Commercial Officer
GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-019282 · doc4.xml · nonDerivative · entry 1

King Sasha · CIK 0001721150 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,500

F1 · shares: The reported securities are represented by restricted stock units, 1/4th of which shall vest on June 1, 2019 and 1/4th of which shall vest on each anniversary thereafter.

Read SEC document
June 29, 2018 Filed Jul 3, 2018 17:43 UTC
Nelles Mitchell JChief Operating Officer
GrantEmployee Stock Option (right to buy) · Derivative 10,000 $0.00 Strike: $12.24 $0.00
Disclosure

SEC source: 0000899243-18-019286 · doc4.xml · derivative · entry 7

Nelles Mitchell J · CIK 0001421333 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2028-06-29

F4 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on June 1, 2019 and 1/48th of the shares subject to the option shall vest monthly thereafter.

Read SEC document
June 29, 2018 Filed Jul 3, 2018 17:43 UTC
Nelles Mitchell JChief Operating Officer
GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-019286 · doc4.xml · nonDerivative · entry 2

Nelles Mitchell J · CIK 0001421333 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,639

F2 · shares: The reported securities are represented by restricted stock units, 100% of which were vested upon grant.

Read SEC document
June 29, 2018 Filed Jul 3, 2018 17:43 UTC
Nelles Mitchell JChief Operating Officer
GrantCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-019286 · doc4.xml · nonDerivative · entry 1

Nelles Mitchell J · CIK 0001421333 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,639

F1 · shares: The reported securities are represented by restricted stock units, 1/4th of which shall vest on June 1, 2019 and 1/4th of which shall vest on each anniversary thereafter.

Read SEC document
June 29, 2018 Filed Jul 3, 2018 17:42 UTC
Yee James PChief Medical Officer
GrantEmployee Stock Option (right to buy) · Derivative 10,000 $0.00 Strike: $12.24 $0.00
Disclosure

SEC source: 0000899243-18-019285 · doc4.xml · derivative · entry 3

Yee James P · CIK 0001421336 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2028-06-29

F3 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on June 1, 2019 and 1/48th of the shares subject to the option shall vest monthly thereafter.

Read SEC document
June 29, 2018 Filed Jul 3, 2018 17:42 UTC
Yee James PChief Medical Officer
GrantCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-019285 · doc4.xml · nonDerivative · entry 2

Yee James P · CIK 0001421336 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,102

F2 · shares: The reported securities are represented by restricted stock units, 100% of which were vested upon grant.

Read SEC document
June 29, 2018 Filed Jul 3, 2018 17:42 UTC
Yee James PChief Medical Officer
GrantCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-019285 · doc4.xml · nonDerivative · entry 1

Yee James P · CIK 0001421336 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,102

F1 · shares: The reported securities are represented by restricted stock units, 1/4th of which shall vest on June 1, 2019 and 1/4th of which shall vest on each anniversary thereafter.

Read SEC document
June 29, 2018 Filed Jul 3, 2018 21:36 UTC
Maag PeterDirector · See Remarks
GrantEmployee Stock Option (right to buy) · Derivative 150,000 $0.00 Strike: $12.24 $0.00
Disclosure

SEC source: 0000899243-18-019279 · doc4.xml · derivative · entry 5

Maag Peter · CIK 0001613855 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2028-06-29

F4 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on June 1, 2019 and 1/48th of the shares subject to the option shall vest monthly thereafter.

Read SEC document
June 29, 2018 Filed Jul 3, 2018 21:36 UTC
Maag PeterDirector · See Remarks
GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-019279 · doc4.xml · nonDerivative · entry 2

Maag Peter · CIK 0001613855 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 472,037

F2 · shares: The reported securities are represented by restricted stock units, 100% of which were vested upon grant.

Read SEC document
June 29, 2018 Filed Jul 3, 2018 21:36 UTC
Maag PeterDirector · See Remarks
GrantCommon Stock 150,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-019279 · doc4.xml · nonDerivative · entry 1

Maag Peter · CIK 0001613855 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 422,037

F1 · shares: The reported securities are represented by restricted stock units, 1/4th of which shall vest on June 1, 2019 and 1/4th of which shall vest on each anniversary thereafter.

Read SEC document
June 29, 2018 Filed Jul 3, 2018 21:37 UTC
Bell Michael BrianChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 50,000 $0.00 Strike: $12.24 $0.00
Disclosure

SEC source: 0000899243-18-019280 · doc4.xml · derivative · entry 3

Bell Michael Brian · CIK 0001702824 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2028-06-29

F3 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on June 1, 2019 and 1/48th of the shares subject to the option shall vest monthly thereafter.

Read SEC document
June 29, 2018 Filed Jul 3, 2018 21:37 UTC
Bell Michael BrianChief Financial Officer
GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-019280 · doc4.xml · nonDerivative · entry 2

Bell Michael Brian · CIK 0001702824 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,738

F2 · shares: The reported securities are represented by restricted stock units, 100% of which were vested upon grant.

Read SEC document
June 29, 2018 Filed Jul 3, 2018 21:37 UTC
Bell Michael BrianChief Financial Officer
GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-019280 · doc4.xml · nonDerivative · entry 1

Bell Michael Brian · CIK 0001702824 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,738

F1 · shares: The reported securities are represented by restricted stock units, 1/4th of which shall vest on June 1, 2019 and 1/4th of which shall vest on each anniversary thereafter.

Read SEC document
June 29, 2018 Filed Jul 3, 2018 21:29 UTC GrantCommon Stock 1,197 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-019272 · doc4.xml · nonDerivative · entry 1

Bickerstaff George · CIK 0001329646 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,204

F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Read SEC document
June 29, 2018 Filed Jul 3, 2018 21:23 UTC GrantCommon Stock 1,756 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-019264 · doc4.xml · nonDerivative · entry 1

Goldberg Michael · CIK 0001366412 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132,879

F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Read SEC document
June 29, 2018 Filed Jul 12, 2018 19:19 UTC Amendment
King SashaChief Commercial Officer
Tax withholdingCommon Stock 3,458 $12.24 $42,325.92
Disclosure

SEC source: 0000899243-18-019826 · doc4a.xml · nonDerivative · entry 1

King Sasha · CIK 0001721150 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,042

F1 · kind: This amendment is being filed solely to report the withholding of shares by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of vested restricted stock units.

Read SEC document
June 29, 2018 Filed Jul 12, 2018 19:23 UTC Amendment
Nelles Mitchell JChief Operating Officer
Tax withholdingCommon Stock 1,729 $12.24 $21,162.96
Disclosure

SEC source: 0000899243-18-019829 · doc4a.xml · nonDerivative · entry 1

Nelles Mitchell J · CIK 0001421333 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,910

F1 · kind: This amendment is being filed solely to report the withholding of shares by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of vested restricted stock units.

Read SEC document
June 29, 2018 Filed Jul 12, 2018 19:22 UTC Amendment
Yee James PChief Medical Officer
Tax withholdingCommon Stock 3,458 $12.24 $42,325.92
Disclosure

SEC source: 0000899243-18-019828 · doc4a.xml · nonDerivative · entry 1

Yee James P · CIK 0001421336 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,644

F1 · kind: This amendment is being filed solely to report the withholding of shares by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of vested restricted stock units.

Read SEC document
June 29, 2018 Filed Jul 12, 2018 23:18 UTC Amendment
Bell Michael BrianChief Financial Officer
Tax withholdingCommon Stock 8,645 $12.24 $105,814.80
Disclosure

SEC source: 0000899243-18-019824 · doc4a.xml · nonDerivative · entry 1

Bell Michael Brian · CIK 0001702824 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,093

F1 · kind: This amendment is being filed solely to report the withholding of shares by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of vested restricted stock units.

Read SEC document
June 29, 2018 Filed Jul 12, 2018 23:17 UTC Amendment
Maag PeterDirector · See Remarks
Tax withholdingCommon Stock 17,290 $12.24 $211,629.60
Disclosure

SEC source: 0000899243-18-019823 · doc4a.xml · nonDerivative · entry 1

Maag Peter · CIK 0001613855 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 454,747

F1 · kind: This amendment is being filed solely to report the withholding of shares by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of vested restricted stock units.

Read SEC document
June 20, 2018 Filed Jul 3, 2018 17:11 UTC GrantStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $14.74 $0.00
Disclosure

SEC source: 0000899243-18-019252 · doc4.xml · derivative · entry 2

HAGSTROM WILLIAM A · CIK 0001042875 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2028-06-20

F2 · derivative.exercise_date: 1/12th of the shares subject to the option shall vest on July 20, 2018 and the shares subject to the option shall vest monthly thereafter through June 20, 2019.

Read SEC document
June 20, 2018 Filed Jul 3, 2018 17:11 UTC GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-019252 · doc4.xml · nonDerivative · entry 1

HAGSTROM WILLIAM A · CIK 0001042875 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,532

F1 · shares: The reported securities are represented by restricted stock units which shall vest on June 20, 2019.

Read SEC document
June 20, 2018 Filed Jul 3, 2018 17:20 UTC GrantStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $14.74 $0.00
Disclosure

SEC source: 0000899243-18-019260 · doc4.xml · derivative · entry 2

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2028-06-20

F2 · derivative.exercise_date: 1/12th of the shares subject to the option shall vest on July 20, 2018 and the shares subject to the option shall vest monthly thereafter through June 20, 2019.

Read SEC document
June 20, 2018 Filed Jul 3, 2018 17:20 UTC GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-019260 · doc4.xml · nonDerivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,799

F1 · shares: The reported securities are represented by restricted stock units which shall vest on June 20, 2019.

Read SEC document
June 20, 2018 Filed Jul 3, 2018 21:22 UTC
Cohen Fred EDirector
GrantStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $14.74 $0.00
Disclosure

SEC source: 0000899243-18-019262 · doc4.xml · derivative · entry 2

Cohen Fred E · CIK 0001339358 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2028-06-20

F2 · derivative.exercise_date: 1/12th of the shares subject to the option shall vest on July 20, 2018 and the shares subject to the option shall vest monthly thereafter through June 20, 2019.

Read SEC document
June 20, 2018 Filed Jul 3, 2018 21:22 UTC
Cohen Fred EDirector
GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-019262 · doc4.xml · nonDerivative · entry 1

Cohen Fred E · CIK 0001339358 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,901

F1 · shares: The reported securities are represented by restricted stock units which shall vest on June 20, 2019.

Read SEC document
June 20, 2018 Filed Jul 3, 2018 21:15 UTC GrantStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $14.74 $0.00
Disclosure

SEC source: 0000899243-18-019255 · doc4.xml · derivative · entry 2

Bickerstaff George · CIK 0001329646 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2028-06-20

F2 · derivative.exercise_date: 1/12th of the shares subject to the option shall vest on July 20, 2018 and the shares subject to the option shall vest monthly thereafter through June 20, 2019.

Read SEC document
June 20, 2018 Filed Jul 3, 2018 21:15 UTC GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-019255 · doc4.xml · nonDerivative · entry 1

Bickerstaff George · CIK 0001329646 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,007

F1 · shares: The reported securities are represented by restricted stock units which shall vest on June 20, 2019.

Read SEC document
June 20, 2018 Filed Jul 3, 2018 21:10 UTC GrantStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $14.74 $0.00
Disclosure

SEC source: 0000899243-18-019251 · doc4.xml · derivative · entry 2

Goldberg Michael · CIK 0001366412 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2028-06-20

F2 · derivative.exercise_date: 1/12th of the shares subject to the option shall vest on July 20, 2018 and the shares subject to the option shall vest monthly thereafter through June 20, 2019.

Read SEC document
June 20, 2018 Filed Jul 3, 2018 21:10 UTC GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-019251 · doc4.xml · nonDerivative · entry 1

Goldberg Michael · CIK 0001366412 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 131,123

F1 · shares: The reported securities are represented by restricted stock units which shall vest on June 20, 2019.

Read SEC document
May 24, 2018 Filed May 29, 2018 16:21 UTC
Gagnon Neil10% owner
GiftCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001019056-18-000745 · caredx_4.xml · nonDerivative · entry 1

GAGNON NEIL · CIK 0001070170 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 878,768

Read SEC document
April 26, 2018 Filed Apr 30, 2018 17:48 UTC
Gagnon Neil10% owner
PurchaseCommon Stock 10,136 $9.42 $95,481.12
Disclosure

SEC source: 0001019056-18-000573 · caredx_4.xml · nonDerivative · entry 1

GAGNON NEIL · CIK 0001070170 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Managing Member as General Partner of Gagnon Investment Associates

Disclosed balance after: 965,894

Read SEC document
April 02, 2018 Filed Apr 4, 2018 18:52 UTC GrantCommon Stock 1,373 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-009492 · doc4.xml · nonDerivative · entry 1

HAGSTROM WILLIAM A · CIK 0001042875 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,532

F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Read SEC document
April 02, 2018 Filed Apr 4, 2018 18:52 UTC GrantCommon Stock 2,221 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-009491 · doc4.xml · nonDerivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,799

F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Read SEC document
April 02, 2018 Filed Apr 4, 2018 22:52 UTC GrantCommon Stock 2,221 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-009490 · doc4.xml · nonDerivative · entry 1

Bickerstaff George · CIK 0001329646 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,007

F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Read SEC document
April 02, 2018 Filed Apr 4, 2018 22:49 UTC GrantCommon Stock 3,258 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-009487 · doc4.xml · nonDerivative · entry 1

Goldberg Michael · CIK 0001366412 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 126,123

F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Read SEC document
March 27, 2018 Filed Mar 28, 2018 20:46 UTC
Maag PeterDirector · See Remarks
SaleCommon Stock 15,000 $7.87 $118,035.00
Disclosure

SEC source: 0000899243-18-008719 · doc4.xml · nonDerivative · entry 1

Maag Peter · CIK 0001613855 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 272,037

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.63 to $8.01, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.